172 related articles for article (PubMed ID: 7486082)
1. Effect of the inhibitor of nitric oxide synthase, NG-nitro-L-arginine methyl ester, on cerebral and myocardial blood flows during hypoxia in the awake dog.
Audibert G; Saunier CG; Siat J; Hartemann D; Lambert J
Anesth Analg; 1995 Nov; 81(5):945-51. PubMed ID: 7486082
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia, alpha 2-adrenergic, and nitric oxide-dependent interactions on canine cerebral blood flow.
McPherson RW; Koehler RC; Traystman RJ
Am J Physiol; 1994 Feb; 266(2 Pt 2):H476-82. PubMed ID: 7511347
[TBL] [Abstract][Full Text] [Related]
3. Endothelium-derived nitric oxide does not modulate metabolic coronary vasodilation induced by tachycardia in dogs.
Katsuda Y; Egashira K; Akatsuka Y; Narishige T; Shimokawa H; Takeshita A
J Cardiovasc Pharmacol; 1995 Sep; 26(3):437-44. PubMed ID: 8583786
[TBL] [Abstract][Full Text] [Related]
4. The dose-related effects of nitric oxide synthase inhibition on cerebral blood flow during isoflurane and pentobarbital anesthesia.
Todd MM; Wu B; Warner DS; Maktabi M
Anesthesiology; 1994 May; 80(5):1128-36. PubMed ID: 7517107
[TBL] [Abstract][Full Text] [Related]
5. Influence of chronic nitric oxide inhibition of coronary blood flow regulation: a study of the role of endogenous adenosine in anesthetized, open-chested dogs.
Tayama S; Okumura K; Matsunaga T; Tsunoda R; Tabuchi T; Iwasa A; Yasue H
Jpn Circ J; 1998 May; 62(5):371-8. PubMed ID: 9626906
[TBL] [Abstract][Full Text] [Related]
6. The role of nitric oxide on fetal cardiovascular control during normoxia and acute hypoxia in 0.75 gestation sheep.
Coumans AB; Garnier Y; Supçun S; Jensen A; Hasaart TH; Berger R
J Soc Gynecol Investig; 2003 Jul; 10(5):275-82. PubMed ID: 12853088
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide-dependent and -independent components of cerebrovasodilation elicited by hypercapnia.
Iadecola C; Zhang F
Am J Physiol; 1994 Feb; 266(2 Pt 2):R546-52. PubMed ID: 7511352
[TBL] [Abstract][Full Text] [Related]
8. Fetal cerebral and peripheral circulatory responses to hypoxia after nitric oxide synthase inhibition.
Harris AP; Helou S; Gleason CA; Traystman RJ; Koehler RC
Am J Physiol Regul Integr Comp Physiol; 2001 Aug; 281(2):R381-90. PubMed ID: 11448839
[TBL] [Abstract][Full Text] [Related]
9. Role of nitric oxide in the elevation of cerebral blood flow induced by acetylcholine and anoxia in the turtle.
Hylland P; Nilsson GE; Lutz PL
J Cereb Blood Flow Metab; 1996 Mar; 16(2):290-5. PubMed ID: 8594061
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic effects of nitric oxide synthase inhibition before and after cardiac arrest in infant piglets.
Schleien CL; Kuluz JW; Gelman B
Am J Physiol; 1998 Apr; 274(4):H1378-85. PubMed ID: 9575943
[TBL] [Abstract][Full Text] [Related]
11. Cerebrovascular consequences of repeated exposure to NG-nitro-L-arginine methyl ester.
Kelly PA; Ritchie IM; Collins FM
Br J Pharmacol; 1995 Nov; 116(6):2771-7. PubMed ID: 8591003
[TBL] [Abstract][Full Text] [Related]
12. Cerebral metabolic recovery from deep hypothermic circulatory arrest after treatment with arginine and nitro-arginine methyl ester.
Hiramatsu T; Jonas RA; Miura T; duPlessis A; Tanji M; Forbess JM; Holtzman D
J Thorac Cardiovasc Surg; 1996 Sep; 112(3):698-707. PubMed ID: 8800158
[TBL] [Abstract][Full Text] [Related]
13. Cerebral blood flow in primates is increased by isoflurane over time and is decreased by nitric oxide synthase inhibition.
McPherson RW; Kirsch JR; Tobin JR; Ghaly RF; Traystman RJ
Anesthesiology; 1994 Jun; 80(6):1320-7. PubMed ID: 7516627
[TBL] [Abstract][Full Text] [Related]
14. Effects of H2-receptor blockers on response of cerebral blood flow to normocapnic hypoxia.
Audibert G; Saunier C; Hartemann D; Bigard O; Haberer JP
Anesth Analg; 1991 Apr; 72(4):532-7. PubMed ID: 1672490
[TBL] [Abstract][Full Text] [Related]
15. Role of nitric oxide, adenosine, N-methyl-D-aspartate receptors, and neuronal activation in hypoxia-induced pial arteriolar dilation in rats.
Pelligrino DA; Wang Q; Koenig HM; Albrecht RF
Brain Res; 1995 Dec; 704(1):61-70. PubMed ID: 8750962
[TBL] [Abstract][Full Text] [Related]
16. Contribution of nitric oxide to coronary vasodilation during hypercapnic acidosis.
Gurevicius J; Salem MR; Metwally AA; Silver JM; Crystal GJ
Am J Physiol; 1995 Jan; 268(1 Pt 2):H39-47. PubMed ID: 7530920
[TBL] [Abstract][Full Text] [Related]
17. NO contributes to neurohypophysial but not other regional cerebral fluorocarbon-induced hyperemia in cats.
Wagner BP; Stingele R; Williams MA; Wilson DA; Traystman RJ; Hanley DF
Am J Physiol; 1997 Oct; 273(4):H1994-2000. PubMed ID: 9362271
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of nitric oxide synthase does not affect alpha 2-adrenergic-mediated cerebral vasoconstriction.
McPherson RW; Kirsch JR; Traystman RJ
Anesth Analg; 1994 Jan; 78(1):67-72. PubMed ID: 7505532
[TBL] [Abstract][Full Text] [Related]
19. Effects of NG-nitro-L-arginine methyl ester on the cardiovascular system of the anaesthetized rabbit and on the cardiovascular response to thyrotropin-releasing hormone.
Seligsohn EE; Bill A
Br J Pharmacol; 1993 Aug; 109(4):1219-25. PubMed ID: 8401932
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine.
Pfeiffer S; Leopold E; Schmidt K; Brunner F; Mayer B
Br J Pharmacol; 1996 Jul; 118(6):1433-40. PubMed ID: 8832069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
